Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-15 Purchase | 2022-03-17 4:05 pm | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 12,000 | $8.39 | $100,680 | 12,000 (Direct) | View |
| 2022-03-14 Purchase | 2022-03-16 4:46 pm | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 10,000 | $8.1934 | $81,934 | 20,000 (Indirect) | View |
| 2022-01-04 Purchase | 2022-01-06 4:06 pm | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 10,000 | $16.36 | $163,650 | 10,000 (Indirect) | View |
| 2021-12-29 Purchase | 2022-01-03 7:59 pm | BridgeBio Pharma Inc. | BBIO | SAUNDERS BRENT L Director | 17,600 | $14.48 | $254,880 | 17,600 (Direct) | View |
| 2021-12-29 Purchase | 2022-01-03 7:57 pm | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 7,500 | $13.18 | $98,850 | 253,682 (Indirect Direct) | View |
| 2021-12-29 Purchase | 2022-01-03 7:53 pm | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 1,764 | $14.23 | $25,102 | 1,764 (Direct) | View |
| 2021-12-29 Purchase | 2022-01-03 7:50 pm | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 19,300 | $14.17 | $273,390 | 19,300 (Direct) | View |
| 2021-12-29 Purchase | 2022-01-03 7:47 pm | BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director | 80,000 | $14.5 | $1,160,000 | 88,491 (Direct) | View |
| 2021-12-28 Purchase | 2021-12-30 8:17 pm | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 22,147 | $13.49 | $298,679 | 10,402 (Direct) | View |
| 2021-12-28 Sale | 2021-12-30 8:17 pm | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 11,745 | $12.8 | $150,336 | 10,402 (Direct) | View |
| 2021-08-04 Sale | 2021-08-06 6:08 pm | BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks | 13,777 | $53.23 | $733,317 | 85,471 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-16 Option Award | 2022-03-18 4:26 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 489,456 | $0 | 489,456 (Direct) | View |
| 2022-03-16 Option Award | 2022-03-18 4:24 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 193,543 | $0 | 193,543 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-15 5:37 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director | 25,566 | $0 | 25,566 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-15 5:34 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 30,078 | $0 | 30,078 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 4:35 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 3,085 | $8.84 | 7,610,545 (Direct) | View |
| 2022-02-16 Exercise | 2022-02-18 4:35 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 15,048 | $0 | 7,610,545 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-18 4:35 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 1,020 | $8.84 | 331,080 (Direct) | View |
| 2022-02-16 Exercise | 2022-02-18 4:35 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 4,976 | $0 | 331,080 (Direct) | View |
| 2021-12-03 Option Award | 2021-12-07 6:14 pm | N/A 2031-12-02 | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 786,072 | $0 | 786,072 (Direct) | View |
| 2021-12-03 Option Award | 2021-12-07 6:05 pm | N/A 2031-12-02 | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 226,510 | $0 | 226,510 (Direct) | View |
| 2021-12-02 Option Award | 2021-12-06 8:58 pm | 2022-12-02 2031-12-01 | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 55,011 | $0 | 55,011 (Direct) | View |
| 2021-12-02 Option Award | 2021-12-06 8:55 pm | 2022-12-02 2031-12-01 | BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Director | 45,566 | $0 | 45,566 (Direct) | View |
| 2021-11-16 Tax Withholding | 2021-11-18 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 3,730 | $47.25 | 7,613,630 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-18 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 15,046 | $0 | 7,613,630 (Direct) | View |
| 2021-11-16 Tax Withholding | 2021-11-18 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 1,234 | $47.25 | 331,595 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-18 4:05 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 4,976 | $0 | 331,595 (Direct) | View |
| 2021-10-25 Option Award | 2021-10-26 9:16 pm | N/A 2031-10-24 | BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director | 50,968 | $0 | 50,968 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-26 5:15 pm | N/A 2031-08-16 | BridgeBio Pharma Inc. | BBIO | Dachille Douglas A. Director | 49,869 | $0 | 49,869 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-26 5:14 pm | N/A 2031-08-16 | BridgeBio Pharma Inc. | BBIO | Hassan Fred Director | 49,869 | $0 | 49,869 (Direct) | View |
| 2021-08-17 Option Award | 2021-08-26 5:14 pm | N/A 2031-08-16 | BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director | 49,869 | $0 | 49,869 (Direct) | View |
| 2021-08-16 Exercise | 2021-08-18 4:10 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 4,974 | $0 | 332,829 (Direct) | View |
| 2021-08-16 Tax Withholding | 2021-08-18 4:10 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C See Remarks | 1,028 | $49.48 | 332,829 (Direct) | View |
| 2021-08-16 Exercise | 2021-08-18 4:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 15,046 | $0 | 7,617,360 (Direct) | View |
| 2021-08-16 Tax Withholding | 2021-08-18 4:06 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO | 3,730 | $49.48 | 7,617,360 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-06 6:08 pm | N/A N/A | BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks | 13,777 | $17 | 85,471 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-06 6:08 pm | N/A 2029-06-26 | BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H See Remarks | 13,777 | $0 | 85,471 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 8:00 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:38 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Lo Andrew Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:21 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:16 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | HOMCY CHARLES J Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:15 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | DANIELS RONALD J Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:08 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | SAUNDERS BRENT L Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 7:03 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | Cook Jennifer E. Director | 38,895 | $0 | 38,895 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 6:51 pm | N/A 2031-06-16 | BridgeBio Pharma Inc. | BBIO | SCHELLER RICHARD H Chairman | 38,895 | $0 | 38,895 (Direct) | View |